股價逼近200元關口!海天味業(603288.SH)逆勢上漲續創新高
格隆匯9月2日丨大牛股海天味業(603288.SH)今日漲勢繼續,盤中一度逆勢漲4.19%至196.58元,逼近200元關口,市值超6300億元,超越了美的集團、寧德時代、恆瑞醫藥等,位居A股第11位,成為了日常消費品行業中市值僅次於貴州茅台和五糧液的企業。對於海天味業今年火箭式的上漲走勢,市場人士普遍認為這並非是業績驅動,更多的是遊資炒作所致。數據顯示,2020年上半年,海天味業實現營收115.95億元,同比增14.12%;歸母淨利32.53億元,同比增18.27%。而海天味業年內的累漲幅度接近120%,目前市盈率已超100倍。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.